Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Table S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
Home
Publications
Table S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
Table S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
Authors:
TQ
Tianyu Qu
Tianyu Qu
LS
Lei Song
Lei Song
JX
Jiali Xu
Jiali Xu
XL
Xiyi Lu
Xiyi Lu
DY
Dandan Yin
Dandan Yin
JD
Jiali Dai
Jiali Dai
CZ
Chen Zhang
Chen Zhang
RG
Renhua Guo
Renhua Guo
EZ
Erbao Zhang
Erbao Zhang
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
15 August 2025
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/0008-5472.29919015
Abstract
A list of top five potential MYLK-AS1-interacting protein candidates in PC9/GR cells based on RNA-protein pull-down assays and mass spectrometry analysis.
Keywords
DRUG RESISTANCE
GENOME BIOLOGY
NON-CODING RNAS & MICRORNAS
LUNG CANCER
Related articles
Scroll to top